Yes mmq1, any results obtained will provide further evidence to what will hopefully be further efficacy and safety, at the same time as helping the lives of boys and parents and importantly giving some further hope of advancements.
You would have to consider that if anyone on the trial had improvement with no adverse effects that they would continue on with the extension.
The 2b trial opens some doors to more pathways and most likely less skepticism by agencies and regulators, and more confidence by families and support groups.
Chart, page-1259
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.5¢ |
Change
-0.001(1.32%) |
Mkt cap ! $67.61M | |||
| Open | High | Low | Value | Volume |
| 7.6¢ | 7.7¢ | 7.5¢ | $38.88K | 514.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 39300 | 7.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.9¢ | 26315 | 1 |
View Market Depth
| Last trade - 15.19pm 21/05/2024 (20 minute delay) ? |
|
|||||
|
Last
7.8¢ |
Change
-0.001 ( 1.27 %) |
||||
| Open | High | Low | Volume | ||
| 7.6¢ | 7.8¢ | 7.5¢ | 112689 | ||
| Last updated 15.50pm 21/05/2024 ? | |||||
| PER (ASX) Chart |